Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

BIOLOGICAL ASSETS - Disclosure of reconciliation of changes in biological assets (Details)

v3.24.1
BIOLOGICAL ASSETS - Disclosure of reconciliation of changes in biological assets (Details)
$ in Thousands
12 Months Ended
Dec. 31, 2022
CAD ($)
Disclosure of detailed information about biological assets [abstract]  
Beginning Balance $ 1,687
Production costs capitalized 7,744
Changes in fair value less cost to sell due to biological transformation 84
Transferred to inventory upon harvest (9,025)
Restructuring disposal (108)
Foreign exchange translation 62
Deconsolidation of Trichom (444)
Ending Balance $ 0